导师风采
崔巍

个人信息

Personal Information

  • 性别:女
  • 导师类型:博士生导师
  • 职称:研究员
  • 该职称任职时间:20090701

联系方式

Contact Information

  • 所属院系:肿瘤医院
  • 所属专业:
  • 邮箱 : wendycuiwei@sina.cn
  • 工作电话 : 01087788448

个人简介

Personal Profile

崔巍,研究员,博士研究生导师,检验科主任,哈佛大学波士顿儿童医院博士后。中国协和医科大学北京协和医院博士。专业为临床基础检验和血液学检验、分子免疫检验等。现任中华医学会检验分会侯任主任委员,中华检验医学杂志副总编辑,国际实验血液学学会细胞分析和流式委员会委员(ISLH Cellular Analysis & Flow Cytometry Committee),亚太临床生物化学与检验医学会(APFCB)教育委员会主席,国际临床化学和实验室医学联盟临床实验室管理委员会(IFCC EMD)通讯委员,多种国内外杂志审稿专家等。荣获中华医学科技奖、中华预防医学科技奖、北京市科技进步奖、华夏医学科技奖等7项。承担国家级和省部级等课题20余项。发表文章200余篇,编著学术著作10余本。

团队简介

Team Profile

待补充更新

  • 研究方向Research Directions
生物标志物的临床应用研究
  • 在校研究生Current Graduate Students

硕士研究生 0 名,博士研究生 7 名

  • 科研项目Research Projects
# 项目名称 起止日期 金额 项目类型 本人角色
1基于多组学分析的基因组及其关联的血清代谢组在胰腺癌发生发展中的作用研究2023-01-01 —— 2026-12-3178.0
2基于多组学分析的基因组及其关联的血清代谢组在胰腺癌发生发展中的作用研究 2023-01-01 —— 2026-12-3152.0主持在研的国家或省部级科研项目主持者
3循环肿瘤细胞自动化检测分析系统研发及临床应用2023-11 —— 2027-101200主持在研的国家或省部级科研项目主持
  • 发表论文Papers
# 论文题目 期刊名称 发表年份 论文署名
1 Pyroptosis correlates with tumor immunity and prognosis.Communications Biology2023-07-03崔巍
2An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinomaRespiratory Research2023-07-03崔巍
3HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal CancerCancers2023-07-03崔巍
4TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistanceCell Death and Disease2023-07-03崔巍
5High proportion of circulating CD8 CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal carcinorma afer radiotherapyJournal of Translational Medicine2023-07-03崔巍
6Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysisFrontiers in oncology2023-07-03崔巍
7凝血相关指标基于576例肝细胞癌患者预后中的预测价值研究肿瘤学杂志2023-07-03崔巍
8基于MALDI-TOF MS的血清多肽组学在胰腺良恶性疾病鉴别诊断中的应用检验医学2023-07-03崔巍
9外周血细胞形态学多元化递进式教学在检验医学科住培中的应用中国毕业后医学教育2023-07-03崔巍
10人乳头状瘤病毒核酸检测用于宫颈癌筛查中国专家共识中华医学杂志2023-07-03崔巍
11Extended-spectrum beta-lactamase-producing Enterobacteriaceaerelated urinary tract infection in adult cancer patients: a multicenter retrospective study, 2015–2019BMC Infectious Diseases 2023-07-03崔巍
12Identification of a Prognostic Risk-Scoring Model and Risk Signatures Based on Glycosylation-Associated Cluster in Breast Cancer Frontiers in Genetics2023-07-03崔巍
13Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-b signaling pathway Gynecologic Oncology2022-05-31崔巍
14.Establishment of the intelligent verification criteria for a routine urinalysis analyzer in a multi-center studyClin Chem Lab Med2022-05-31崔巍
15DNA N6-methyladenine modification in hypertension. Aging (Albany NY)2022-05-31崔巍
16Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma.OncoTargets and Therapy2022-05-31崔巍
17miR-1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancerOncology Reports2022-05-31崔巍
18Association of N6-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts.Cell Death & Disease2022-05-31崔巍
19 Accelerated telomere shortening independent of LRRK2 variants in Chinese patients with Parkinson's disease Aging2022-05-31崔巍
20Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal aquanmous cell carcinoma: A propensity score-matched analysisThorac Cancer2022-05-31崔巍
21Serum KLKBI as a potential prognostic biomarker for hepatocellular carcinoma based on data-independent acquisiton and parallel reaction monitoringJournal of Hepatocellular Carcinoma2022-05-31崔巍
22Predict Major Complications and Survival in Colorectal Liver Metastases Patients After Resection Translational Oncology2022-05-31崔巍
23Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC. Journal of Cancer Research and Clinical Oncology2022-05-31崔巍
24HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 ClusterFrontiers in Cell and Developmental Biology2022-05-31崔巍
25 YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 CoMutationCells2022-05-31崔巍
26Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancerThorac Cancer2022-05-31崔巍
27 Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.GUT2022-05-31崔巍
28Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms Am J Reprod Immunol2022-05-31崔巍
29分层教学模式在检验医师规范化培训临床分子生物学教学中的应用 中国毕业后医学教育2024-01通讯作者
30beta-lactamase-produing Enterobacteriaceae related urinary tract infection in adult canser patients: a multicenter retrospective study, 2015-2019. BMC Infectious Diseases. BMC Infectious Diseases2023-12通讯作者
31实体肿瘤外周血细胞免疫功能实验室检测专家共识中华检验医学杂志2023-12通讯作者
32基于多参数流式细胞术精细化分析外周血 免疫细胞亚群的中国专家共识 中华预防医学杂志2023-11通讯作者
  • 科研获奖Research Awards
# 获奖证书编号 奖项名称 获奖级别 获奖类别 获奖等级 获奖日期 颁奖单位 本单位是否为第一完成单位 完成单位排名 本人排序 备注
12022-J117-R3指导肿瘤个体化诊疗的液体活检关键技术创新与临床应用省部级科技进步奖、哲学社科奖二等奖2023-12-15中国医疗保健国际交流促进会13
2201403041P0801基于流式细胞术的细胞表型和分子表型的临床系列应用研究省部级科技进步奖、哲学社科奖三等奖2014-12-29中华医学会11
3 202111036001临床基础检验规范化检测体系的建立及推广应用省部级科技进步奖、哲学社科奖二等奖2021-11-01中华预防医学会11
42002医-2-004-08单倍体相合未去T细胞骨髓移植省部级科技进步奖、哲学社科奖二等奖2002-12-02北京市科技奖励办28
  • 研究成果Research Findings
# 成果类型 项目/专利/新品种名称
1作为主创人员获得授权的发明专利和新品种肝癌患者血清中筛选预后相关蛋白的方法及其应用
2作为主创人员获得授权的发明专利和新品种一种基于血清肽的胰腺癌诊断模型的建立方法及其应用
3作为主创人员获得授权的发明专利和新品种一种临床实验室尿液常规检验自动审核系统
4出版高水平专著1. 血清标志物 中国肿瘤整合诊治技术指南(CACA)
5出版高水平专著检验科医生手册
6出版高水平专著医学检验项目指南-帮你解析化验结果
7出版高水平专著北京协和医院医疗诊疗常规—检验科诊疗常规
8出版高水平专著临床检验诊断学丛书-血液系统疾病
9出版高水平专著检验医学病例与临床思维分析
10出版高水平专著临床血液和体液检验标准化操作程序
11出版高水平专著北京协和医院寄生虫彩色图谱
12出版高水平专著医学检验科诊疗常规
13出版高水平专著肿瘤标志物异常结果分析案例集
14获得新药研究成果血液与体液检验治疗管理